Concepedia

Aarti Kawatkar

AK

Statistics

Publications

7

Citations

380

H-Index

7

Active since

2015

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

AstraZeneca (Germany)

AstraZeneca (Poland)

Aarti Kawatkar is an author at AstraZeneca (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2015–2023

7

Publications

7

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6

William McCoull, Tony Cheung, Erica Anderson et al. · ACS Chemical Biology · 2018 · 139 citations · Full text

, , +14

CETSA beyond Soluble Targets: a Broad Application to Multipass Transmembrane Proteins

Aarti Kawatkar, Michelle Schefter, Nils-Olov Hermansson et al. · ACS Chemical Biology · 2019 · 92 citations

, , +13

Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology

Frederick W. Goldberg, Jason G. Kettle, Gillian M. Lamont et al. · Journal of Medicinal Chemistry · 2022 · 56 citations · Full text

, , +10

Direct activation of KCC2 arrests benzodiazepine refractory status epilepticus and limits the subsequent neuronal injury in mice

Rebecca M. Jarvis, Josephine Ng, Anna Nathanson et al. · Cell Reports Medicine · 2023 · 31 citations · Full text

, , +17

Discovery and Optimization of a Novel Series of Highly Selective JAK1 Kinase Inhibitors

Neil P. Grimster, Erica Anderson, Marat Alimzhanov et al. · Journal of Medicinal Chemistry · 2018 · 26 citations · Full text

, , +12

1–5 of 7